- Home
- NMTC
as 11-14-2024 1:35pm EST
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.
| Founded: | 2009 | Country: | United States |
| Employees: | N/A | City: | EDEN PRAIRIE |
| Market Cap: | 27.7M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 97.0K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.49 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.60 - $2.00 | Next Earning Date: | 12-12-2024 |
| Revenue: | $3,922,499 | Revenue Growth: | -16.13% |
| Revenue Growth (this year): | 109.53% | Revenue Growth (next year): | 90.00% |
Latest NeuroOne Medical Technologies Corporation News
NMTC Breaking Stock News: Dive into NMTC Ticker-Specific Updates for Smart Investing
ACCESSWIRE
2 days ago
NeuroOne Medical Technologies Corporation to Present at November 21st Virtual Investor Summit Microcap Event
GlobeNewswire
14 days ago
NeuroOne® Announces Expansion of Existing Distribution Agreement with Zimmer Biomet for Commercialization of OneRF™ Ablation System
GlobeNewswire
22 days ago
NeuroOne® Medical Technologies to Present at the 2024 ThinkEquity Conference
GlobeNewswire
2 months ago
NeuroOne® Spinal Cord Stimulation Electrode Technology to be Featured at The Business of Pain Conference
GlobeNewswire
2 months ago
NeuroOne® Announces Breakthrough Case Completed with OneRF™ Ablation System at the University Hospitals in Cleveland
GlobeNewswire
2 months ago
NeuroOne® to Present at the H.C. Wainwright 26th Annual Global Investment Conference
GlobeNewswire
3 months ago
NeuroOne® Reports Third Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update
GlobeNewswire
3 months ago
NeuroOne® to Report Third Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on August 14
Compare NMTC vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "NMTC NeuroOne Medical Technologies Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.